BD partners with US government to expand domestic manufacturing of medical consumables

Bitget2026/10/06 10:36

BD entered a partnership with the U.S. government to expand domestic manufacturing of essential medical consumables. Planned investment totals $19 billion over several years, including $3 billion earmarked for U.S. manufacturing expansion. Targeted output increase of about 5 billion consumables a year, lifting BD’s domestically supplied share to roughly 80%. Deal calls for 100% of BD needles used in the U.S. to be made domestically using American-made steel. Agreement offers potential relief from future Section 232 tariffs on covered products, subject to final scope and milestone delivery. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BD - Becton, Dickinson and Company published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610060635PR_NEWS_USPR_____NY64008) on October 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.